As of 3:59pm ET
| +0.07 / +0.96%|
The 3 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 25.00 and a low estimate of 17.00. The median estimate represents a +171.00% increase from the last price of 7.38.
The current consensus among 3 polled investment analysts is to Buy stock in Oramed Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.